Immune Therapy and β-Cell Death in Type 1 Diabetes
Type 1 diabetes (T1D) results from immune-mediated destruction of insulin-producing β-cells. The killing of β-cells is not currently measurable; β-cell functional studies routinely used are affected by environmental factors such as glucose and cannot distinguish death from dysfunction. Moreover, it...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
American Diabetes Association
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636605/ |